The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Genetic profiling reveals an alarming rate of cross‐contamination among human cell lines used in China
Abstract
Cell lines are widely used as in vitro model systems in biologic and medical research. However, much of the research has been invalidated by the unwitting use of false cell lines. A significant proportion of the research involving human cell lines was initiated in China. Paradoxically, the cell lines used in China have never been authenticated. Here, we present a comprehensive survey of cross‐contamination in 380 samples from 113 independent sources in China using short tandem repeat profiling methods. High levels of cross‐contamination were uncovered (95 of 380, 25%). Notable false cell lines ( e.g. , KB and WISH) are still actively used under their false identity and tissue attributions. Most strikingly, 85.51% of lines established in China were misidentified (59 of 69) and accounted for over half of the misidentifications (59 of 95, 62.11%). Further, 93.22% of the contaminants in cell lines established in laboratories of China were HeLa cells or a possible hybrid of HeLa with an unknown cell line. Results from these misidentified lines have been published in thousands of potentially erroneous articles and may have distorted the findings visible to the scientific community. False lines have been used in drug screening, potentially leading to unusable or even harmful therapeutic strategies. We also noted the causes of contamination and provided suggestions for remediation.—Ye, F., Chen, C, Qin, J., Liu, J., Zheng, C. Genetic profiling reveals an alarming rate of cross‐contamination among human cell lines used in China. FASEB J. 29, 4268‐4272 (2015). www.fasebj.org
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Our lab started using STR for cell line authentication from 2009 with 16/20-loci STR and found about 25% cross-contamination or misidentification among 380 cell lines from 2009 to 2013 [6].”
From Investigation of Cross-Contamination and Misidentification of 278 Widely Used Tumor Cell Lines (2017) · cites this paper as [6]
In the citing paper
“An alarming rate of cross-contamination among human cell lines used in China was reported by Fang Ye and colleagues [6] who investigated 380 human cell lines in which about 25% was cross-contaminated or misidentified.”
From Investigation of Cross-Contamination and Misidentification of 278 Widely Used Tumor Cell Lines (2017) · cites this paper as [6]
In the citing paper
“In spite of several alarm calls and initiatives to remedy the problem, misidentification continues to haunt biomedical research, with new announcements of large-scale cross-contaminations and widespread use of misidentified cell lines appearing even recently [11–13].”
From The ghosts of HeLa: How cell line misidentification contaminates the scientific literature (2017) · cites this paper as [13]
In the citing paper
“Nevertheless, an analysis of the literature for the past five years showed a dramatic rise of China’s share in the contaminated literature, confirming recent worries expressed in the literature [13].”
From The ghosts of HeLa: How cell line misidentification contaminates the scientific literature (2017) · cites this paper as [13]
In the citing paper
“demonstrate that of all ‘new’ cell lines developed in China 85% actually turned out to be HeLa cells [13].”
From The ghosts of HeLa: How cell line misidentification contaminates the scientific literature (2017) · cites this paper as [13]
In the citing paper
“several recent publications indicate levels of cell line contamination for China between 25% [13] and 46% [46]”
From The ghosts of HeLa: How cell line misidentification contaminates the scientific literature (2017) · cites this paper as [13]
In the citing paper
“A 2015 STR profile of 380 samples from 113 independent labs uncovered a 25% (95/380) CCCM rate [153].”
From The history, landscape, and outlook of human cell line authentication and security (2024) · cites this paper as [153]
In the citing paper
“More than three quarters of the lines established in China were misidentified [153].”
From The history, landscape, and outlook of human cell line authentication and security (2024) · cites this paper as [153]
In the citing paper
“This revealed that in 185/420 (44%) papers, all 8 NV identifiers could represent misspellings of similarly named cell lines, which were typically HeLa-contaminated cancer cell lines (38–41).”
From Misspellings or “miscellings”—Non‐verifiable and unknown cell lines in cancer research publications (2024) · cites this paper as [38]
In the citing paper
“Two NV identifiers (BGC-803, BSG-823) were recognized misspellings (26) of the contaminated cell lines BGC-823 or MGC-803 (38–41)”
From Misspellings or “miscellings”—Non‐verifiable and unknown cell lines in cancer research publications (2024) · cites this paper as [38]
In the citing paper
“These NV cell lines were also not described by studies describing STR profiles for similarly named contaminated cell lines (38–41).”
From Misspellings or “miscellings”—Non‐verifiable and unknown cell lines in cancer research publications (2024) · cites this paper as [38]
In the citing paper
“and 3 NV cell lines (BGC-803, GSE-1, MGC-823) were described as sourced from the China Center for Type Culture Collection (38–41).”
From Misspellings or “miscellings”—Non‐verifiable and unknown cell lines in cancer research publications (2024) · cites this paper as [38]
Citations
Cites
HeLa cells 50 years on: the good, the bad and the ugly
Masters, J. R. (2002) · Nature Reviews Cancer · doi:10.1038/nrc775 · Cited by 560
Check your cultures! A list of cross‐contaminated or misidentified cell lines
Capes‐Davis, A., Theodosopoulos, G., Atkin, I., Drexler, H. G., Kohara, A., MacLeod, R. A. F., Masters, J. R., Nakamura, Y., Reid, Y. A., Reddel, R. R., et al. (2010) · International Journal of Cancer · doi:10.1002/ijc.25242 · Cited by 520 · cited 1×
“The contribution andproportion of contaminants are similar to other reports (4, 26).”
Cross-contamination of cells in culture
Nelson-Rees, W. A., Daniels, D. W., & Flandermeyer, R. R. (1981) · Science · doi:10.1126/science.6451928 · Cited by 329
Cell line misidentification: the beginning of the end
American Type Culture Collection Standards Development Organization Workgroup ASN-0002 (2010) · Nature Reviews Cancer · doi:10.1038/nrc2852 · Cited by 266
Henrietta lacks, HeLa cells, and cell culture contamination
Lucey, B. P., Nelson-Rees, W. A., & Hutchins, G. M. (2009) · Archives of Pathology & Laboratory Medicine · doi:10.5858/133.9.1463 · Cited by 255
Apparent HeLa Cell Contamination of Human Heteroploid Cell Lines
GARTLER, S. M. (1968) · Nature · doi:10.1038/217750a0 · Cited by 226
False leukemia–lymphoma cell lines: an update on over 500 cell lines
Drexler, H. G., Dirks, W. G., Matsuo, Y., & MacLeod, R. A. F. (2003) · Leukemia · doi:10.1038/sj.leu.2402799 · Cited by 202
Match criteria for human cell line authentication: Where do we draw the line?
Capes‐Davis, A., Reid, Y. A., Kline, M. C., Storts, D. R., Strauss, E., Dirks, W. G., Drexler, H. G., MacLeod, R. A. F., Sykes, G., Kohara, A., et al. (2013) · International Journal of Cancer · doi:10.1002/ijc.27931 · Cited by 180 · cited 1×
“The Tanabe matching algorithm (13) was used to compare STR profiles with the referenced profiles.”
MethodSpecies identification in cell culture: a two-pronged molecular approach
Cooper, J. K., Sykes, G., King, S., Cottrill, K., Ivanova, N. V., Hanner, R., & Ikonomi, P. (2007) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/s11626-007-9060-2 · Cited by 174 · cited 1×
“(14), was performed for those cell lines from which genomic DNA failed to be amplified using our multiplex PCR system.”
MethodPersistent use of “false” cell lines
Lacroix, M. (2008) · International Journal of Cancer · doi:10.1002/ijc.23233 · Cited by 151
Research works printed but not linked: 1
- Chen S., 2009, False leukemia and lymphoma cell lines, Int. J. Blood Transfus. Hematol., 32, 342
Cited by
Sorted by citations
The Curious Case of the HepG2 Cell Line: 40 Years of Expertise
Arzumanian, V. A., Kiseleva, O. I., & Poverennaya, E. V. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222313135 · Cited by 387
Cystathionine-β-synthase: Molecular Regulation and Pharmacological Inhibition
Zuhra, K., Augsburger, F., Majtán, T., & Szabó, C. (2020) · Biomolecules · doi:10.3390/biom10050697 · Cited by 244
The ghosts of HeLa: How cell line misidentification contaminates the scientific literature
Horbach, S. P. J. M., & Halffman, W. (2017) · PLOS ONE · doi:10.1371/journal.pone.0186281 · Cited by 167
Application of Animal Models in Cancer Research: Recent Progress and Future Prospects
Li, Z., Zheng, W., Wang, H., Cheng, Y., Fang, Y., Wu, F., Sun, G., Sun, G., Lv, C., & Hui, B. (2021) · Cancer Management and Research · doi:10.2147/cmar.s302565 · Cited by 151
Pamies, D. (2018) · ALTEX · doi:10.14573/altex.1710081 · Cited by 127
21st Century Cell Culture for 21st Century Toxicology
Pamies, D., & Härtung, T. (2016) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.6b00269 · Cited by 126
Investigation of Cross-Contamination and Misidentification of 278 Widely Used Tumor Cell Lines
Huang, Y., Liu, Y., Zheng, C., & Shen, C. (2017) · PLOS ONE · doi:10.1371/journal.pone.0170384 · Cited by 105
Self-citationBian, X., Yang, Z., Feng, H., Sun, H., & Liu, Y. (2017) · Scientific Reports · doi:10.1038/s41598-017-09660-w · Cited by 86
More Than an Adipokine: The Complex Roles of Chemerin Signaling in Cancer
Goralski, K. B., Jackson, A. E., McKeown, B. T., & Sinal, C. J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20194778 · Cited by 80
Epstein–Barr Virus and Innate Immunity: Friends or Foes?
Jangra, S., Yuen, K., Botelho, M. G., & Jin, D. (2019) · Microorganisms · doi:10.3390/microorganisms7060183 · Cited by 74
Cell line authentication: a necessity for reproducible biomedical research
Souren, N. Y., Fusenig, N. E., Heck, S., Dirks, W. G., Capes‐Davis, A., Bianchini, F., & Plass, C. (2022) · The EMBO Journal · doi:10.15252/embj.2022111307 · Cited by 73
Fusenig, N. E., Capes-Davis, A., Bianchini, F., Sundell, S., & Lichter, P. (2017) · PLOS Biology · doi:10.1371/journal.pbio.2001438 · Cited by 66
Hayder, H., Shan, Y., Chen, Y., O’Brien, J. A., & Peng, C. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.995462 · Cited by 50
Inflammatory effects of hexavalent chromium in the lung: A comprehensive review
Kouokam, J. C., Meaza, I., & Wise, J. P. (2022) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2022.116265 · Cited by 53
Corral-Vázquez, C., Aguilar-Quesada, R., Catalina, P., Lucena-Aguilar, G., Ligero, G., Miranda, B., & Carrillo-Ávila, J. A. (2017) · Cell and Tissue Banking · doi:10.1007/s10561-017-9617-6 · Cited by 47
Marine Anthraquinones: Pharmacological and Toxicological Issues
Greco, G., Turrini, E., Catanzaro, E., & Fimognari, C. (2021) · Marine Drugs · doi:10.3390/md19050272 · Cited by 42
Zhang, J., Zheng, G., Zhou, L., Li, P., Yun, M., Shi, Q., Wang, T., & Wu, X. (2018) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2018.3769 · Cited by 40
Cross‐contamination of the human salivary gland HSG cell line with HeLa cells: A STR analysis study
Lin, L., Elkashty, O. A., Ramamoorthi, M., Trinh, N., Liu, Y., Sunavala‐Dossabhoy, G., Pranzatelli, T. J. F., Michael, D. G., Chivasso, C., Perret, J., et al. (2018) · Oral Diseases · doi:10.1111/odi.12920 · Cited by 36
Han, Y., Song, C., Zhang, T., Zhou, Q., Zhang, X., Wang, J., Xu, B., Zhang, X., Liu, X., & Ying, X. (2020) · Cell Cycle · doi:10.1080/15384101.2020.1817666 · Cited by 35
Deng, L., Chao, H., Deng, H., Yu, Z., Zhao, R., Huang, L., Gong, Y. Y., Zhu, Y., Wang, Q., Li, F., et al. (2022) · BMC Cancer · doi:10.1186/s12885-022-09616-y · Cited by 35
Stop using the misidentified cell line LO2 as a human hepatocyte
Shao, T., & Chen, Y.-L. (2024) · Journal of Hepatology · doi:10.1016/j.jhep.2023.10.036 · Cited by 34
Computational estimation of quality and clinical relevance of cancer cell lines
Trastulla, L., Noorbakhsh, J., Vazquez, F., McFarland, J., & Iorio, F. (2022) · Molecular Systems Biology · doi:10.15252/msb.202211017 · Cited by 31
The Culture of Cell Culture Practices and Authentication—Results from a 2015 Survey
Freedman, L. P., Gibson, M. C., Wisman, R., Ethier, S. P., Soule, H. R., Reid, Y. A., & Neve, R. M. (2015) · BioTechniques · doi:10.2144/000114344 · Cited by 31
Schwartz‐Duval, A. S., & Sokolov, K. (2022) · Advanced Science · doi:10.1002/advs.202105957 · Cited by 29
Orexins/Hypocretins and Cancer: A Neuropeptide as Emerging Target
Couvineau, A., Nicole, P., Gratio, V., & Voisin, T. (2021) · Molecules · doi:10.3390/molecules26164849 · Cited by 28
Guo, H., Liang, S., Wang, Y., Zhou, S., Yin, D., Zhang, S., Wang, J., Wu, D., Ma, K., Liu, Y., et al. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05053-8 · Cited by 24
What do cellular responses to acidity tell us about cancer?
Błaszczak, W., & Swietach, P. (2021) · Cancer and Metastasis Reviews · doi:10.1007/s10555-021-10005-3 · Cited by 23
Zhang, H., Wei, Z., Tong, Y., Song, X., Li, S., Sun, Y., Liu, C., Han, F., & Yu, J. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.116628 · Cited by 23
Zhao, Z., Cai, Z., Zhang, S., Yin, X., Jiang, T., Shen, C., Yin, Y., Sun, H., Chen, Z., Han, J., et al. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.216796 · Cited by 20
Mora‐Lagos, B., Cartas‐Espinel, I., Riquelme, I., Parker, A., Piccolo, S., Viscarra, T., Reyes, M. E., Zanella, L., Buchegger, K., Ili, C., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0228331 · Cited by 20
Cancer clocks in tumourigenesis: the p53 pathway and beyond
Stephenson, E. M., Usselmann, L. E. J., Tergaonkar, V., Virshup, D. M., & Dallmann, R. (2021) · Endocrine Related Cancer · doi:10.1530/erc-20-0475 · Cited by 20
Rapid detection of low‐level HeLa cell contamination in cell culture using nested PCR
Lin, J., Chen, L., Jiang, W., Zhang, H., Shi, Y., & Cai, W. (2018) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13923 · Cited by 20
Optimization of cell lines as tumour models by integrating multi-omics data
Zhao, N., Liu, Y., Wei, Y., Yan, Z., Zhang, Q., Wu, C., Chang, Z., & Xu, Y. (2016) · Briefings in Bioinformatics · doi:10.1093/bib/bbw082 · Cited by 20
Chen, X., Qian, W., Song, Z., Li, Q.-X., & Guo, S. (2020) · NAR Genomics and Bioinformatics · doi:10.1093/nargab/lqaa060 · Cited by 19
Biggi, A. F. B., & de Oliveira, D. E. (2022) · Biomolecules · doi:10.3390/biom12030397 · Cited by 22
Misspellings or “miscellings”—Non‐verifiable and unknown cell lines in cancer research publications
Oste, D. J., Pathmendra, P., Richardson, R. A. K., Johnson, G., Ao, Y., Arya, M. D., Enochs, N. R., Hussein, M., Kang, J., Lee, A., et al. (2024) · International Journal of Cancer · doi:10.1002/ijc.34995 · Cited by 18
Circular RNAs in Epithelial Ovarian Cancer: From Biomarkers to Therapeutic Targets
Qiu, Y., Chen, Y., Agbede, O., Eshaghi, E., & Peng, C. (2022) · Cancers · doi:10.3390/cancers14225711 · Cited by 19
Targeting Ca2+ Signaling in the Initiation, Promotion and Progression of Hepatocellular Carcinoma
Ali, E. S., Rychkov, G. Y., & Barritt, G. J. (2020) · Cancers · doi:10.3390/cancers12102755 · Cited by 19
Mechanisms of Apoptosis-Related Long Non-coding RNAs in Ovarian Cancer
Takeiwa, T., Ikeda, K., Horie‐Inoue, K., & Inoue, S. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.641963 · Cited by 17
Korch, C. T., & Varella‐Garcia, M. (2018) · Advances in Molecular Pathology · doi:10.1016/j.yamp.2018.07.003 · Cited by 16
Li, H., Yin, N., Yang, R., & Faiola, F. (2024) · Environment & Health · doi:10.1021/envhealth.3c00199 · Cited by 16
Preclinical Models of Neuroblastoma—Current Status and Perspectives
Krawczyk, E., & Kitlinska, J. B. (2023) · Cancers · doi:10.3390/cancers15133314 · Cited by 16
Voon, K. J., Sivasothy, Y., Sundralingam, U., Lalmahomed, A., & Goh, A. P. (2022) · Pharmaceuticals · doi:10.3390/ph15121517 · Cited by 15
Melo, G., Silva, C. A. B., Hague, A., Parkinson, E. K., & Rivero, E. R. C. (2022) · Oral Oncology · doi:10.1016/j.oraloncology.2022.105979 · Cited by 15
Letter to the Editor: LO2, a misidentified cell line: Some data should be interpreted with caution
Weiskirchen, R. (2022) · Hepatology · doi:10.1002/hep.32730 · Cited by 13
Established Liver Cell Lines: Are You Sure to Have the Right Ones?
Weiskirchen, R. (2022) · Livers · doi:10.3390/livers2030015 · Cited by 12
Genetic physical unclonable functions in human cells
Li, Y., Bidmeshki, M. M., Kang, T., Nowak, C. M., Makris, Y., & Bleris, L. (2022) · Science Advances · doi:10.1126/sciadv.abm4106 · Cited by 12
Sheets, J. N., Patrick, M. E., & Egland, K. A. (2020) · Oncotarget · doi:10.18632/oncotarget.27626 · Cited by 12
West, A. J., Deswaerte, V., West, A. C., Gearing, L. J., Tan, P. B. O., & Jenkins, B. J. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.830350 · Cited by 12
Feng, H., Zhang, Y., Liu, K., Zhu, Y., Yang, Z., Zhang, X., & Liu, Y. (2017) · International Journal of Cancer · doi:10.1002/ijc.30674 · Cited by 12
Gu, M., Yang, M., He, J., Xia, S., Zhang, Z., Wang, Y., Zheng, C., & Shen, C. (2022) · International Journal of Cancer · doi:10.1002/ijc.33789 · Cited by 11
Self-citationJesenko, T., Kranjc, S., Čemažar, M., Biasin, A., Tierno, D., Scaggiante, B., Grassi, M., Grassi, C., Dapas, B., Truong, N. H., et al. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15041249 · Cited by 11
Chen, Y., Lin, G., Wang, Z., He, J., Yang, G., Lin, Z., Gong, C., Liu, N., Li, F., Tong, D., et al. (2024) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2024.116668 · Cited by 10
Differential expression of EphA5 protein in gastric carcinoma and its clinical significance
Zhang, W., Wei, X., Guo, S., Wang, J., Liu, J., & Wang, H. (2019) · Oncology Letters · doi:10.3892/ol.2019.10167 · Cited by 10
Self-citationReagent Validation to Facilitate Experimental Reproducibility
Williams, M. J. (2018) · Current Protocols in Pharmacology · doi:10.1002/cpph.40 · Cited by 10
The history, landscape, and outlook of human cell line authentication and security
Harbut, E., Makris, Y., Pertsemlidis, A., & Bleris, L. (2024) · SLAS Discovery · doi:10.1016/j.slasd.2024.100194 · Cited by 8
Riel, M., & Johannsen, E. (2025) · Current topics in microbiology and immunology · doi:10.1007/82_2025_330 · Cited by 8
Dual-Channel NIR Fluorescence Imaging for Precise Delineation of Gastric Tumor Margins
Ji, Y., Bao, K., Mei, L., Su, Y., Wu, Y., Li, C., Wu, Y., Ge, Z., Choi, S.-K., Wang, Z., et al. (2025) · Biomaterials Research · doi:10.34133/bmr.0275 · Cited by 8
Nasopharyngeal Carcinoma Cell Lines: Reliable Alternatives to Primary Nasopharyngeal Cells?
Makowska, A. M., & Weiskirchen, R. (2024) · Cells · doi:10.3390/cells13070559 · Cited by 8
Fu, N., Li, D., Li, W., Zhao, W. T., Zhang, S., Liu, L., Zhao, S., Du, J., Kong, L., Wang, R., et al. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.00199 · Cited by 8
Integrin-Linked Kinase Is a Novel Therapeutic Target in Ovarian Cancer
Ulm, M. A., Redfern, T., Wilson, B., Ponnusamy, S., Asemota, S., Blackburn, P., Wang, Y., ElNaggar, A. C., & Narayanan, R. (2020) · Journal of Personalized Medicine · doi:10.3390/jpm10040246 · Cited by 8
Design and synthesis of Aza-boeravinone derivatives as potential novel topoisomerase I inhibitors
Zhou, Y. C., Bai, Y.-P., Zhang, M., Gao, J.-M., Yang, C., Zhang, Z., Deng, N., Li, L., Liu, Y., & Xu, C. (2022) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2022.105747 · Cited by 8
“Cell identity” crisis: Another call for immediate action
de Oliveira, D. E., Marques, C. S., & Losi, V. C. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.07.031 · Cited by 8
Du, Y., Zhao, J., Li, X., Huang, S.-C., Ning, N., Chen, G., Yang, Y. T., Nan, Y., & Yuan, L. (2024) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v16.i1.30 · Cited by 7
Zhou, Y., Zhang, W., Tang, X., Mao, B., Hung, W., He, J., Du, J., Jiang, Q., Feng, H., Zhao, J., et al. (2025) · Food Bioscience · doi:10.1016/j.fbio.2025.107323 · Cited by 7
Yip, Y., Lin, W., Deng, W., Tsang, C., & Tsao, S. W. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814936-2.00005-5 · Cited by 7
Li, D., Ding, L. J., Yan, Y., Xing, Y., Xu, J., & Qin, L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242316848 · Cited by 7
Du, C., Wang, Y., Li, H., Huang, Y. H., Jiang, O., You, Y., & Luo, F. (2017) · Oncology Letters · doi:10.3892/ol.2017.6710 · Cited by 6
Weiskirchen, R. (2025) · Research Integrity and Peer Review · doi:10.1186/s41073-025-00170-2 · Cited by 5
Intact-cell MALDI-ToF mass spectrometry for the authentication of drug-adapted cancer cell lines
Povey, J. F., Saintas, E., Aderemi, A. V., Rothweiler, F., Zehner, R., Dirks, W. G., Cinatl, J., Racher, A. J., Wass, M. N., Smales, C. M., et al. (2019) · Cells · doi:10.3390/cells8101194 · Cited by 5
Du, X., He, K., Huang, Y., Xu, Z., Kong, M., Zhang, J., Cao, J., & Teng, L. (2020) · International Journal of Oncology · doi:10.3892/ijo.2020.4965 · Cited by 5
HeLa cells cross-contaminated nasopharyngeal carcinoma cell lines: Still a common problem
Makowska, A., Kontny, U., & Weiskirchen, R. (2024) · British Journal of Cancer · doi:10.1038/s41416-024-02675-x · Cited by 5
Wardrup, K. C., Hoffman, J., Pandya, M. J., Navarathna, N., Tulapurkar, M. E., & Padmanabhan, A. (2025) · npj Precision Oncology · doi:10.1038/s41698-025-01153-8 · Cited by 4
Vorobyov, I. I., Fedorov, A. Y., & Gorbunova, Y. G. (2026) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2026.218101 · Cited by 4
Personalized Medicine in Oncology
Vanderwalde, A. M. (2022) · MDPI eBooks · doi:10.3390/books978-3-0365-2820-5 · Cited by 4
Incorrect cell line validation and verification
da Silva, J. A. T. (2018) · Annals of Translational Medicine · doi:10.21037/atm.2018.02.23 · Cited by 4
There is a Scientific Need for the Right Leukemia-Lymphoma Cell Lines
Drexler, H. G., Eberth, S., Nagel, S., & Quentmeier, H. (2019) · HemaSphere · doi:10.1097/hs9.0000000000000315 · Cited by 4
Mansour, N. M., Balas, E. A., Yang, F. M., & Vernon, M. (2020) · Medical Science Monitor · doi:10.12659/msm.922016 · Cited by 4
Weiskirchen, R. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.1002484 · Cited by 4
Research reporting guidelines for cell lines: more than just a recommendation
Weiskirchen, R. (2023) · Annals of Translational Medicine · doi:10.21037/atm-23-1208 · Cited by 4
Three-Dimensional Culture Systems in Neuroblastoma Research
Jung, P., & Wolpaw, A. J. (2025) · Organoids · doi:10.3390/organoids4020010 · Cited by 3
Layman, A. J., Alsbrook, S., Koturbash, I., & McGill, M. R. (2024) · Journal of Dietary Supplements · doi:10.1080/19390211.2024.2335573 · Cited by 3
Role of formyl peptide receptor 2 in steatosis of L02 cells exposed to Mono‐(2‐ethylhexyl) phthalate
Feng, X., Zhang, R., Miao, X., Xu, L., Cui, J., Xu, H., Fang, X., Zhou, C., Ye, L., & Zhou, L. (2024) · Environmental Toxicology · doi:10.1002/tox.24256 · Cited by 3
Experimental Planning and Execution
Mullane, K., Curtis, M. J., & Williams, M. J. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804725-5.00002-1 · Cited by 3
Editors, T. P. O. (2024) · PLoS ONE · doi:10.1371/journal.pone.0301556 · Cited by 3
RetractedZhan, S., Huang, J., Liu, Y., Han, F., Wang, J., Wang, Q., & Huang, Z. (2025) · Biological Trace Element Research · doi:10.1007/s12011-024-04492-y · Cited by 2
Byrne, J. A. (2025) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000007854 · Cited by 2
Andrews, J. M., Lloyd, M. W., Neuhauser, S. B., Bundy, M., Jocoy, E. L., Airhart, S. D., Bult, C. J., Evrard, Y. A., Chuang, J. H., & Baker, S. J. (2024) · Bioinformatics · doi:10.1093/bioinformatics/btae713 · Cited by 2
Translational studies on pancreatic cancer and gastric cancer: a methodology in PhD thesis
Resell, M., Qvigstad, G., Wang, T. C., Quante, A. S., González‐Fernández, Á., Waldum, H. L., Chen, D., & Zhao, C. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1604017 · Cited by 2
Yan, Q., Jiang, L., Liu, M., Yu, D., Zhang, Y., Li, Y., Fang, S., Li, Y., Zhu, Y., Yuan, Y., et al. (2022) · Cancer Research · doi:10.1158/0008-5472.can-22-2783 · Cited by 2
RetractedConditionally Reprogrammed Cells as Preclinical Model for Rare Cancers
Krawczyk, E. (2025) · Cancers · doi:10.3390/cancers17172834 · Cited by 1
Makowska, A. M., Buhl, E. M., Göschel, M., Kuo, C., Nothbaum, C., Toktamis, E. A., Shen, L., Abdallah, A. T., Weiskirchen, R., & Kontny, U. (2025) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2025.152053 · Cited by 1
Establishment and Application of a 16‐Loci STR Method for Rat Cell Line Authentication
Yang, M., Xu, T., Li, N., Sun, Y., Huang, W., Liang, X., & Shen, C. (2025) · The FASEB Journal · doi:10.1096/fj.202501145r · Cited by 1
Weiskirchen, R. (2025) · Food and Chemical Toxicology · doi:10.1016/j.fct.2025.115599 · Cited by 1
Weiskirchen, R. (2025) · RSC Advances · doi:10.1039/d5ra00388a · Cited by 1
Natural phenolic compounds as modulators of radiation response in hepatocellular carcinoma
Imani, A., & Rassouli, F. B. (2026) · Clinical and Experimental Medicine · doi:10.1007/s10238-026-02166-8 · Cited by 1
Artifacts of analysis in cell line identification by short tandem repeat profiling
Malchenkova, A. A., & Kosobokova, E. N. (2024) · CARDIOVASCULAR THERAPY AND PREVENTION · doi:10.15829/1728-8800-2024-4121 · Cited by 1
Time profile of nimotuzumab for enhancing radiosensitivity of the Eca109 cell line
Li, J., Wang, L., Qiu, Z., & Su, Y. (2019) · Oncology Letters · doi:10.3892/ol.2019.9897 · Cited by 1
Epigenetic Reprogramming by Endocrine Disrupting Chemicals
Chung, F. F., Khoueiry, R., & Herceg, Z. (2020) · Royal Society of Chemistry eBooks · doi:10.1039/9781839160738-00025 · Cited by 1
Editors, T. P. G. (2022) · PLoS Genetics · doi:10.1371/journal.pgen.1010332 · Cited by 1
Metadata
- Authors
- Ye, F., Chen, C., Qin, J., Liu, J., & Zheng, C.
- Affiliations
- Wuhan University (CN)
- Beijing Microread Genetics Company, Limited Beijing China
- Corresponding author
- Zheng, Congyi
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2015-06-26
- Volume
- 29
- Issue
- 10
- Pages
- 4268-4272
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2157825735
- Cited by
- 144
- References
- 28
- Citations by year
- 2026: 15 · 2025: 28 · 2024: 17 · 2023: 11 · 2022: 24 · 2021: 11 · 2020: 12 · 2019: 7 · 2018: 6 · 2017: 9 · 2016: 3 · 2015: 1
- FWCI
- 2.75
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The FASEB Journal (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Identification and Quantification in Food
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Viral Infectious Diseases and Gene Expression in Insects
- Health Sciences › Health Professions › Medical Laboratory Technology › Clinical Laboratory Practices and Quality Control
- Keywords
- human cell lines, cross-contamination, cell line authentication, short tandem repeat profiling, HeLa cells, KB cells
- MeSH terms
- China, DNA, Neoplasm, HeLa Cells, Humans, Polymerase Chain Reaction, Sequence Analysis, DNA, Microsatellite Repeats, Biomedical Research, Cell Line, Tumor, DNA Contamination
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
